This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
The FDA approved five new drugs in 2021 for use for genetic conditions, including molybdenum cofactor deficiency, Von Hippel-Lindau (VHL)…
Article
11 months ago ●
12 mins read
Context. “Compound 39” (RAPT Therapeutics) is a general control nonderepressible 2 (GCN2) protein kinase inhibitor. As the master regulator of…
molecule
5 months ago ●
5 mins read
There were two novel small molecules approved in April 2022: mavacamten (Camzyos), an oral cardiac myosin inhibitor oteseconazole (Vivjoy), an…
Article
11 months ago ●
9 mins read
Context. Neflamapimod (EIP Pharma, VX-745) is an oral, brain-penetrant p38α kinase inhibitor under development for neurodegenerative disorders. Among the roles…
molecule
5 months ago ●
5 mins read
Recently, Dr. Alf Claesson (CEO of Awametox AB, inventor of SpotRM, and previously Principal Scientist and Section Head at AstraZeneca/Astra…
Article
11 months ago ●
4 mins read
Context. Upacicalcet (Sanwa Kagaku Kenkyusho Co) is a calcium-sensing receptor (CaSR) agonist being developed for secondary hyperparathyroidism (SHPT). The IV…
molecule
5 months ago ●
3 mins read
Load More
